Japan has the same regulations and practices for nutraceuticals, food, and beverage goods as any other nation. Legitimate safety regulations, regulatory protectionism, and customs taxes present manufacturers with significant obstacles when they attempt to enter the market. The Ministry of Health, Labour, and Welfare (MHLW) and Consumer Affairs Agency (CAA) are in charge of enforcing the Food […]
Read More →The clinical research landscape is shifting drastically due to an increase in the availability of electronic data allowing researchers to make assessments based on available real-world evidence (RWE) obtained from the analysis of real-world data (RWD). Global regulators are encouraging researchers/drug developers utilize the RWE for submissions. Many regulators are accepting the Real-world evidence (RWE) […]
Read More →After changes in the regulatory system, Japan has become the largest market for clinical trials in the Asia-Pacific region for both local and global studies, and Japan is now a country of choice in clinical development maps. But still, you need a proper strategy to accelerate the drug development process in Japan. Previously it would […]
Read More →Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To import and have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Note: This article […]
Read More →Japan is one of the world’s leading cosmetic and personal care products (beauty products) markets. The experts assume the beauty and personal care products market to grow at a CAGR of 3.5% over the next five years. Cosmetics shipments within Japan generate a market value of around 2.7 trillion Japanese yen. Due to this market […]
Read More →The conduct of clinical trials is a critical process. Along with resource hiring, it also requires materials for different activities. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products necessary for the conduct of clinical trials. It becomes critical to plan for procurement or import of […]
Read More →The use of dietary supplements and nutraceutical to lower risks for illness and enhance health has gained popularity in Japan over the past few decades. The shipment value of health foods in Japan reached about 888 billion Japanese yen in the fiscal year 2021, continuing the upward trend from previous years. The market was expected […]
Read More →Do you know, according to clinicaltrials.gov, a total of 354,130 clinical trials were registered worldwide with 71,256 ongoing clinical trials as recorded on Oct-2020? The number of clinical trials is increasing year by year from 56.16k in 2017 to 60.69k in 2018. In the USA, more than 2.3+ million people participate in approximately 80,000+ clinical […]
Read More →Drug development is a lengthy, complex, and costly process entrenched with a high uncertainty that a drug will successfully reach the market. So for this, you need a proper drug development strategy to avoid uncertainties and complete clinical trials in time with quality data. Drug development is the process to bring a new pharmaceutical drug […]
Read More →Drug development is the process of bringing a new pharmaceutical drug to the market after identifying a lead compound through drug discovery. The drug development process starts from drug discovery and ends gaining market approval and post-marketing studies, This entire process of medical device/drug development takes years and depends on many factors such as Type […]
Read More →